Loading...
UroGen Pharma Ltd.
URGN•NASDAQ
HealthcareBiotechnology
$7.37
$2.23(43.39%)
UroGen Pharma Ltd. (URGN) Quarterly Earnings Reports & Financial Results
Analyze UroGen Pharma Ltd.’s revenue, EPS, and earnings surprises to assess performance and investor sentiment over recent quarters.
Total Reports
0
Avg EPS
N/A
Avg Revenue
N/A
Beats Estimates
0 out of 0
Max EPS
N/A
Min EPS
N/A
Earnings Visualization
Visual comparison of UroGen Pharma Ltd.’s actual vs. estimated earnings across recent quarters.
No data available
UroGen Pharma Ltd. (URGN) Quarterly Earnings Details
Detailed breakdown of UroGen Pharma Ltd.’s earnings per share (EPS), revenue estimates vs. actuals, and earnings surprises by quarter.